Every open market buy and sale of Biomarin Pharmaceutical Inc stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $4.6M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when BMRN insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an BMRN officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every BMRN insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 18, 2026 | Gregory R FribergEVP, Chief R&D Officer | Sale | 5,147 | $58.81 | $303K | 42,585 | Nov 19Form 4 |
| Sep 2, 2026 | George Eric DavisEVP, Chief Legal Officer | Sale | 17,557 | $66.28 | $1.2M | 61,003 | Sep 3Form 4 |
| May 7, 2026 | Gregory R FribergEVP, Chief R&D Officer | Sale | 3,281 | $53.85 | $177K | 51,818 | May 11Form 4 |
| Mar 11, 2026 | Charles Greg GuyerEVP, Chief Technical Officer | Sale | 16,486 | $60.46 | $997K | 79,953 | Mar 12Form 4 |
| Feb 26, 2026 | George Eric DavisEVP, Chief Legal Officer | Sale | 26,061 | $61.36 | $1.6M | 72,453 | Feb 26Form 4 |
| Feb 26, 2026 | Gregory R FribergEVP, Chief R&D Officer | Sale | 6,326 | $60.38 | $382K | 37,578 | Feb 26Form 4 |
| May 20, 2025 | Erin BurkhartGVP, Chief Accounting Officer | Sale plan | 1,786 | $59.31 | $106K | 14,173 | May 20Form 4 |
| May 2, 2025 | Cristin HubbardEVP, Chief Commercial Officer | Sale plan | 273 | $64.92 | $18K | 32,700 | May 6Form 4 |
| Mar 19, 2025 | Erin BurkhartGVP, Chief Accounting Officer | Sale plan | 1,295 | $71.52 | $93K | 16,955 | Mar 20Form 4 |
| Mar 6, 2025 | Charles Greg GuyerEVP, Chief Technical Officer | Sale | 7,034 | $71.28 | $501K | 87,655 | Mar 7Form 4 |
| Feb 24, 2025 | Erin BurkhartGVP, Chief Accounting Officer | Sale plan | 1,344 | $68.38 | $92K | 13,105 | Feb 25Form 4 |
| Nov 12, 2024 | Charles Greg GuyerEVP, Chief Technical Officer | Sale | 5,278 | $66.37 | $350K | 68,909 | Nov 14Form 4 |
BMRN insider trading FAQ
Are BMRN insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of BMRN on the open market in 0 trades, and 3 sold $4.6M in 6 trades.
When did an BMRN insider last buy shares?
There has been no open market insider purchase of BMRN in the last two years.
When did an BMRN insider last sell shares?
Gregory R Friberg (EVP, Chief R&D Officer) sold 5,147 shares for $303K on Nov 18, 2026.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
